Interestingly, chemokines or chemokine receptors exhibiting consistent hypermethylation and underexpression in cancer, exhibited expression patterns across tumors that were more likely to be consistently negatively correlated with expression of EZH2 or DNMT1 (or both) (Figure 4B and C). The gene discussed is EZH2; the disease is cancer.